News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event News Rest Easy Pest Control Implements Internal CRM System Designed by Marketing Director to Improve Service Operations News Ciscom Corp. Announces Results of Its Annual Shareholders’ Meeting News Digital Lifestyle Expert Mario Armstrong and News Media Group, Inc. Reveal Top Tech Gifts for the Holidays in 2025 on a Nationwide Satellite Media Tour News Metavista3D Launches 3D Digital Microscope News Giang Huy Logistics Expands Digital Cross-Border Order Services Between China and Vietnam
